Journal of Clinical Endocrinology & Metabolism, Vol 80, 2607-2611, Copyright © 1995 by Endocrine Society

ARTICLES

Rarity of oncogenic mutations in the thyrotropin receptor of autonomously functioning thyroid nodules in Japan

A Takeshita, Y Nagayama, N Yokoyama, N Ishikawa, K Ito, T Yamashita, T Obara, Y Murakami, K Kuma and J Takamatsu
First Department of Internal Medicine, Nagasaki University School of Medicine, Japan.

Constitutively activating mutations have recently been identified in the thyrotropin receptor (TSHR) of hyperfunctioning thyroid adenomas and familial hyperthyroidism. In the present study, we evaluated the frequency of constitutively activating TSHR mutations in a large series of autonomously functioning thyroid nodules (AFTNs) in Japan. Forty- five AFTNs (38 solitary hyperfunctioning thyroid adenomas and 7 toxic multinodular goiters) were analyzed. Genomic DNA was extracted from paraffin-embedded tissue sections, from which DNA fragments encoding the mutational hot spots of the receptor (the third cytoplasmic loop and the sixth transmembrane segment) were amplified by polymerase chain reaction. In the single-stranded conformation polymorphism (SSCP) analysis, only one hyperfunctioning adenoma (no. 21) displayed a migration abnormality. In sequence analysis, an unusual mutation of alternate three-base deletions at nucleotides 1953-1957 (AAA GAT ACC to AAG TCC), resulting in one amino acid deletion (Asp at 619) and one conservative amino acid substitution (Thr to Ser at 620), was identified in tumor DNA but not in leukocyte DNA of no. 21. Further, the normal sequence in these regions was confirmed in 10 randomly selected samples with normal migrating patterns in SSCP analysis. The functional property of the mutant with delta 619 and T620S (designated TSHR delta 619) was then evaluated with in vitro mutagenesis and transfection studies. Unexpectedly, however, there were no significant differences in TSH binding affinity, and basal and TSH-stimulated levels of cAMP and inositol 1,4,5-triphosphate between the TSHR delta 619 and the wt-TSHR. In conclusion, the incidence of the constitutively activating TSHR mutations in AFTNs appears to be low in Japan. The oncogenic potential of a novel somatic mutant TSHR delta 619 identified in a hyperfunctioning adenoma in this study is at present uncertain because of its intact function.

This article has been cited by other articles:

				H. I. Gozu, R. Bircan, K. Krohn, S. Muller, S. Vural, C. Gezen, H. Sargin, D. Yavuzer, M. Sargin, B. Cirakoglu, et al. Similar prevalence of somatic TSH receptor and Gs{alpha} mutations in toxic thyroid nodules in geographical regions with different iodine supply in Turkey. Eur. J. Endocrinol., October 1, 2006; 155(4): 535 - 545. [Abstract] [Full Text] [PDF]

				K. Krohn and R. Paschke Progress in Understanding the Etiology of Thyroid Autonomy J. Clin. Endocrinol. Metab., July 1, 2001; 86(7): 3336 - 3345. [Full Text] [PDF]

				E. M. Gabriel, E. R. Bergert, C. S. Grant, J. A. van Heerden, G. B. Thompson, and J. C. Morris Germline Polymorphism of Codon 727 of Human Thyroid-Stimulating Hormone Receptor Is Associated with Toxic Multinodular Goiter J. Clin. Endocrinol. Metab., September 1, 1999; 84(9): 3328 - 3335. [Abstract] [Full Text]

				D. H. C. Khoo, J. Parma, C. Rajasoorya, S. C. Ho, and G. Vassart A Germline Mutation of the Thyrotropin Receptor Gene Associated with Thyrotoxicosis and Mitral Valve Prolapse in a Chinese Family J. Clin. Endocrinol. Metab., April 1, 1999; 84(4): 1459 - 1462. [Abstract] [Full Text]

				H. Fujiwara, K.-I. tatsumi, K. Miki, T. Harada, S. Okada, O. Nose, S. Kodama, and N. Amino Recurrent T354P Mutation of the Na+/I- Symporter in Patients with Iodide Transport Defect J. Clin. Endocrinol. Metab., August 1, 1998; 83(8): 2940 - 2943. [Abstract] [Full Text]

				P. Wonerow, T. Schoneberg, G. Schultz, T. Gudermann, and R. Paschke Deletions in the Third Intracellular Loop of the Thyrotropin Receptor. A NEW MECHANISM FOR CONSTITUTIVE ACTIVATION J. Biol. Chem., April 3, 1998; 273(14): 7900 - 7905. [Abstract] [Full Text] [PDF]

				R. Paschke and M. Ludgate The Thyrotropin Receptor in Thyroid Diseases N. Engl. J. Med., December 4, 1997; 337(23): 1675 - 1681. [Full Text] [PDF]

				D. Fuhrer, H.-P. Holzapfel, P. Wonerow, W. A. Scherbaum, and R. Paschke Somatic Mutations in the Thyrotropin Receptor Gene and Not in the Gs{alpha} Protein Gene in 31 Toxic Thyroid Nodules J. Clin. Endocrinol. Metab., November 1, 1997; 82(11): 3885 - 3891. [Abstract] [Full Text] [PDF]

				J. Parma, L. Duprez, J. Van Sande, J. Hermans, P. Rocmans, G. Van Vliet, S. Costagliola, P. Rodien, J. E. Dumont, and G. Vassart Diversity and Prevalence of Somatic Mutations in the Thyrotropin Receptor and Gs{alpha} Genes as a Cause of Toxic Thyroid Adenomas J. Clin. Endocrinol. Metab., August 1, 1997; 82(8): 2695 - 2701. [Abstract] [Full Text] [PDF]

				R. J. Clifton-Bligh, J. W. Gregory, M. Ludgate, R. John, L. Persani, C. Asteria, P. Beck-Peccoz, and V. K. K. Chatterjee Two Novel Mutations in the Thyrotropin (TSH) Receptor Gene in a Child with Resistance to TSH J. Clin. Endocrinol. Metab., April 1, 1997; 82(4): 1094 - 1100. [Abstract] [Full Text] [PDF]

				C. Esapa, S. Foster, S. Johnson, J. L. Jameson, P. Kendall-Taylor, and P. E. Harris G Protein and Thyrotropin Receptor Mutations in Thyroid Neoplasia J. Clin. Endocrinol. Metab., February 1, 1997; 82(2): 493 - 496. [Abstract] [Full Text] [PDF]

				E. Davies, A. Bonnardeaux, P.-F. Plouin, P. Corvol, and E. Clauser Somatic Mutations of the Angiotensin II (AT1) Receptor Gene are Not Present in Aldosterone-Producing Adenoma J. Clin. Endocrinol. Metab., February 1, 1997; 82(2): 611 - 615. [Abstract] [Full Text] [PDF]

				L. Duprez, J. Hermans, J. Van Sande, J. E. Dumont, G. Vassart, and J. Parma Two Autonomous Nodules of a Patient with Multinodular Goiter Harbor Different Activating Mutations of the Thyrotropin Receptor Gene J. Clin. Endocrinol. Metab., January 1, 1997; 82(1): 306 - 308. [Full Text] [PDF]